Filtered By:
Condition: Asthma
Vaccination: Covid Vaccine

This page shows you your search results in order of date.

Order by Relevance | Date

Total 341 results found since Jan 2013.

Vaccine-elicited B and T cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients
CONCLUSIONS: Deep immune phenotyping of the SARS-CoV-2 vaccine response revealed the complex nature of vaccine-elicited immunity and highlights the need for more personalised vaccination schemes in patients with underlying lung conditions.PMID:37583809 | PMC:PMC10423317 | DOI:10.1183/23120541.00400-2023
Source: Cell Research - August 16, 2023 Category: Cytology Authors: Haolin Liu Katja Aviszus Pearlanne Zelarney Shu-Yi Liao Anthony N Gerber Barry Make Michael E Wechsler Philippa Marrack R Lee Reinhardt Source Type: research

Oral Nirmatrelvir and Ritonavir for Covid-19 in Vaccinated, Non-Hospitalized Adults, Ages 18-50 Years
CONCLUSION: NMV-r use in vaccinated adults aged 18-50, especially with serious comorbidities, was associated with reduced all-cause hospital visits, hospitalization, and mortality in the first 30 days of Covid-19 illness. However, NMR-r in patients without significant comorbidities or with only asthma/COPD had no association of benefit. Therefore, identifying high-risk patients should be a priority and avoid over-prescription should be avoided.PMID:37387690 | DOI:10.1093/cid/ciad400
Source: Cancer Control - June 30, 2023 Category: Cancer & Oncology Authors: Jeremy Samuel Faust Ashish Kumar Jui Shah Sumanth Khadke Sourbha S Dani Sarju Ganatra Paul E Sax Source Type: research

Epidemiological study of vaccination against SARS-CoV-2 and its impact on COVID-19 progression in a cohort of patients in gran Canaria
Conclusions. Cancer, coronary heart disease, and immunosuppressive treatment were associated with increased COVID-19 mortality. More complete vaccination was associated with lower risk of hospital admission or death. Three doses of the SARS-CoV-2 vaccine were highly associated with the prevention of death and hospital admission in all age groups. These findings suggest that COVID-19 vaccination can help bring the pandemic under control.PMID:37366493 | PMC:PMC10288311 | DOI:10.1016/j.vacun.2023.06.005
Source: Cancer Control - June 27, 2023 Category: Cancer & Oncology Authors: Alejandro de Arriba Fern ández Jos é Luis Alonso Bilbao Alberto Espi ñeira Francés Antonio Cabeza Mora Ángela Gutiérrez Pérez Miguel Ángel Díaz Barreiros Source Type: research

Necrotizing pancreatitis, microangiopathic hemolytic anemia and thrombocytopenia following the second dose of Pfizer/BioNTech COVID-19 mRNA vaccine
We report a 31-year-old female with a history of borderline personality disorder, intravenous drug abuse, allergic asthma, eating disorder, psoriatic arthritis treated with tofacitinib, neurogenic bladder disturbance, cholecystectomy, recurrent thoracic herpes zoster, vaginal candida infections and urinary tract infections, who developed pancreatitis associated with thrombotic microangiopathy and hemolytic-uremic syndrome 10 days after the second vaccination, whereas the first has been well tolerated. She was treated by plasma exchange, and eventually by transgastric drainage with implantation of a plastic stent to remove ...
Source: Herpes - June 6, 2023 Category: Infectious Diseases Authors: Claudia St öllberger Kastriot Kastrati Clemens Dejaco Martina Scharitzer Josef Finsterer Patrick Bugingo Madeleine Melichart-Kotik Astrid Wilfing Source Type: research

Predictive Attributes for Developing Long COVID-A Study Using Machine Learning and Real-World Data from Primary Care Physicians in Germany
Conclusions: The present exploratory study describes an initial investigation of the prediction of potential features increasing the risk of developing long COVID after COVID-19 infection by using the patient history from electronic medical records before COVID-19 infection in primary care practices in Germany using machine learning. Notably, we identified several predictive features for the development of long COVID in patient demographics and their medical histories.PMID:37240616 | PMC:PMC10219004 | DOI:10.3390/jcm12103511
Source: Pain Physician - May 27, 2023 Category: Anesthesiology Authors: Roman Kessler Jos Philipp Joanna Wilfer Karel Kostev Source Type: research

Future perspectives of emerging novel drug targets and immunotherapies to control drug addiction
This article's main highlight is discussing the drug targets of SUDs and their associated mechanisms. Importantly, we have also discussed the scope of prophylactic measures to eliminate drug dependence.PMID:37099943 | DOI:10.1016/j.intimp.2023.110210
Source: International Immunopharmacology - April 26, 2023 Category: Allergy & Immunology Authors: Jonaid Ahmad Malik Javed N Agrewala Source Type: research

Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and 2 surveys
CONCLUSION: A diagnosis of IIMs confers an equal risk of flares in the post COVID-19 vaccination period to AIRDs, with active disease, female gender, and comorbidities conferring a higher risk. Disparity between patient and physician reported outcomes represents a future avenue for exploration.PMID:37084267 | DOI:10.1093/rheumatology/kead180
Source: Pain Physician - April 21, 2023 Category: Anesthesiology Authors: R Naveen Parikshit Sen Zolt án Griger Jessica Day Mrudula Joshi Arvind Nune Elena Nikiphorou Sreoshy Saha Ai Lyn Tan Samuel Katsuyuki Shinjo Nelly Ziade Tsvetelina Velikova Marcin Milchert Kshitij Jagtap Ioannis Parodis Abraham Edgar Gracia-Ramos Lorenzo Source Type: research

The Application of New Approach Methodologies in Respiratory Disease Research: Their Role in Improving Translational Medicine from Bench to Bedside
We describe their potential uses for efficacy and toxicity assessments, to optimise the drug development process and reduce the high failure rates in clinical trials.PMID:37067473 | DOI:10.1177/02611929231170392
Source: Alternatives to Laboratory Animals : ATLA - April 17, 2023 Category: Research Authors: Artur C G da Silva Marize C Valadares Source Type: research